Magovcevic-Liebisch Ivana
SEC insider (Form 3/4/5 filer). CIK 0001279281. Director at Quanterix Corp (QTRX) and 2 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Oct 2, 2026. Located in BILLERICA, MA.
Companies Magovcevic-Liebisch Ivana has filed insider reports for
- Quanterix Corp (QTRX): Director
- Acrivon Therapeutics, Inc. (ACRV): Director
- Vigil Neuroscience, Inc. (VIGL): Director, Officer, President and CEO
Magovcevic-Liebisch Ivana
CIK: 0001279281
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Oct 2, 2026QTRX
Quanterix Corp
ExerciseDirect4.2K shares- - Jun 17, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - May 18, 2026ACRV
Acrivon Therapeutics, Inc.
AwardDirect9.4K shares- - Jan 2, 2026QTRX
Quanterix Corp
AwardDirect23.4K shares- - Aug 5, 2025VIGL
Vigil Neuroscience, Inc.
DispositionDirect222.7K shares- - Jun 13, 2025ACRV
Acrivon Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20.3K shares- - Mar 3, 2025VIGL
Vigil Neuroscience, Inc.
AwardDirectStock Option Award (Right to Buy)
485K shares- - Jan 2, 2025QTRX
Quanterix Corp
AwardDirect7.4K shares- - Dec 19, 2024VIGL
Vigil Neuroscience, Inc.
PurchaseDirect5K shares at avg. $1.68$8K - Dec 18, 2024VIGL
Vigil Neuroscience, Inc.
PurchaseDirect5K shares at avg. $1.67$8K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 |  QTRX Quanterix Corp | Exercise | 4,224 | - | $0 | Direct |
| Jun 17, 2026 |  ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,275 | - | - | Direct |
| May 18, 2026 | ACRV Acrivon Therapeutics, Inc. | Award | 9,366 | - | $0 | Direct |
| Jan 2, 2026 | QTRX Quanterix Corp | Award | 23,372 | - | $0 | Direct |
| Aug 5, 2025 |  VIGL Vigil Neuroscience, Inc. | Disposition | 222,687 | - | - | Direct |
| Jun 13, 2025 | ACRV Acrivon Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,275 | - | - | Direct |
| Mar 3, 2025 | VIGL Vigil Neuroscience, Inc. | Award Stock Option Award (Right to Buy) | 485,000 | - | - | Direct |
| Jan 2, 2025 | QTRX Quanterix Corp | Award | 7,435 | - | $0 | Direct |
| Dec 19, 2024 | VIGL Vigil Neuroscience, Inc. | Purchase | 5,000 | $1.68 | $8,400 | Direct |
| Dec 18, 2024 | VIGL Vigil Neuroscience, Inc. | Purchase | 5,000 | $1.67 | $8,350 | Direct |
1-10 of 12 transactions